0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HMO Infant Formula Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-34H17237
Home | Market Reports | Health| Nutrition
Global HMO Infant Formula Market Research Report 2024
BUY CHAPTERS

Global HMO Infant Formula Market Research Report 2025

Code: QYRE-Auto-34H17237
Report
March 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HMO Infant Formula Market Size

The global market for HMO Infant Formula was valued at US$ 3860 million in the year 2024 and is projected to reach a revised size of US$ 7850 million by 2031, growing at a CAGR of 10.8% during the forecast period.

HMO Infant Formula Market

HMO Infant Formula Market

Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Global key players of HMO Infant Formula include Nestlé (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HMO Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMO Infant Formula.
The HMO Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HMO Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HMO Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.

Scope of HMO Infant Formula Market Report

Report Metric Details
Report Name HMO Infant Formula Market
Accounted market size in year US$ 3860 million
Forecasted market size in 2031 US$ 7850 million
CAGR 10.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 2'-Fucosyllactose (2'-FL)
  • Others
Segment by Sales Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Mead Johnson(Reckitt), Nestlé(Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HMO Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HMO Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is HMO Infant Formula Market growing?

Ans: The HMO Infant Formula Market witnessing a CAGR of 10.8% during the forecast period 2025-2031.

What is the HMO Infant Formula Market size in 2031?

Ans: The HMO Infant Formula Market size in 2031 will be US$ 7850 million.

What is the market share of major companies in HMO Infant Formula Market?

Ans: The top five players hold a share about 94%.

What is the HMO Infant Formula Market share by region?

Ans: Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately.

Who are the main players in the HMO Infant Formula Market report?

Ans: The main players in the HMO Infant Formula Market are Abbott, Mead Johnson(Reckitt), Nestlé(Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Biostime, Yili Group (Ausnutria Dairy)

What are the Type segmentation covered in the HMO Infant Formula Market report?

Ans: The Types covered in the HMO Infant Formula Market report are 2'-Fucosyllactose (2'-FL), Others

Recommended Reports

Infant Formula Markets

Specialty Formula Types

Organic & Functional

1 HMO Infant Formula Market Overview
1.1 Product Definition
1.2 HMO Infant Formula by Type
1.2.1 Global HMO Infant Formula Market Value Comparison by Type (2024 VS 2031)
1.2.2 2'-Fucosyllactose (2'-FL)
1.2.3 Others
1.3 HMO Infant Formula by Sales Channel
1.3.1 Global HMO Infant Formula Market Value by Sales Channel (2024 VS 2031)
1.3.2 Online Channel
1.3.3 Specialty Store
1.3.4 Supermarket
1.3.5 Others
1.4 Global HMO Infant Formula Market Size Estimates and Forecasts
1.4.1 Global HMO Infant Formula Revenue 2020-2031
1.4.2 Global HMO Infant Formula Sales 2020-2031
1.4.3 Global HMO Infant Formula Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HMO Infant Formula Market Competition by Manufacturers
2.1 Global HMO Infant Formula Sales Market Share by Manufacturers (2020-2025)
2.2 Global HMO Infant Formula Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HMO Infant Formula Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HMO Infant Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HMO Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HMO Infant Formula, Product Type & Application
2.7 Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry
2.8 Global HMO Infant Formula Market Competitive Situation and Trends
2.8.1 Global HMO Infant Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HMO Infant Formula Players Market Share by Revenue
2.8.3 Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HMO Infant Formula Market Scenario by Region
3.1 Global HMO Infant Formula Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HMO Infant Formula Sales by Region: 2020-2031
3.2.1 Global HMO Infant Formula Sales by Region: 2020-2025
3.2.2 Global HMO Infant Formula Sales by Region: 2026-2031
3.3 Global HMO Infant Formula Revenue by Region: 2020-2031
3.3.1 Global HMO Infant Formula Revenue by Region: 2020-2025
3.3.2 Global HMO Infant Formula Revenue by Region: 2026-2031
3.4 North America HMO Infant Formula Market Facts & Figures by Country
3.4.1 North America HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HMO Infant Formula Sales by Country (2020-2031)
3.4.3 North America HMO Infant Formula Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMO Infant Formula Market Facts & Figures by Country
3.5.1 Europe HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HMO Infant Formula Sales by Country (2020-2031)
3.5.3 Europe HMO Infant Formula Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMO Infant Formula Market Facts & Figures by Region
3.6.1 Asia Pacific HMO Infant Formula Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HMO Infant Formula Sales by Region (2020-2031)
3.6.3 Asia Pacific HMO Infant Formula Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMO Infant Formula Market Facts & Figures by Country
3.7.1 Latin America HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HMO Infant Formula Sales by Country (2020-2031)
3.7.3 Latin America HMO Infant Formula Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HMO Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HMO Infant Formula Sales by Country (2020-2031)
3.8.3 Middle East and Africa HMO Infant Formula Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMO Infant Formula Sales by Type (2020-2031)
4.1.1 Global HMO Infant Formula Sales by Type (2020-2025)
4.1.2 Global HMO Infant Formula Sales by Type (2026-2031)
4.1.3 Global HMO Infant Formula Sales Market Share by Type (2020-2031)
4.2 Global HMO Infant Formula Revenue by Type (2020-2031)
4.2.1 Global HMO Infant Formula Revenue by Type (2020-2025)
4.2.2 Global HMO Infant Formula Revenue by Type (2026-2031)
4.2.3 Global HMO Infant Formula Revenue Market Share by Type (2020-2031)
4.3 Global HMO Infant Formula Price by Type (2020-2031)
5 Segment by Sales Channel
5.1 Global HMO Infant Formula Sales by Sales Channel (2020-2031)
5.1.1 Global HMO Infant Formula Sales by Sales Channel (2020-2025)
5.1.2 Global HMO Infant Formula Sales by Sales Channel (2026-2031)
5.1.3 Global HMO Infant Formula Sales Market Share by Sales Channel (2020-2031)
5.2 Global HMO Infant Formula Revenue by Sales Channel (2020-2031)
5.2.1 Global HMO Infant Formula Revenue by Sales Channel (2020-2025)
5.2.2 Global HMO Infant Formula Revenue by Sales Channel (2026-2031)
5.2.3 Global HMO Infant Formula Revenue Market Share by Sales Channel (2020-2031)
5.3 Global HMO Infant Formula Price by Sales Channel (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott HMO Infant Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Mead Johnson(Reckitt)
6.2.1 Mead Johnson(Reckitt) Company Information
6.2.2 Mead Johnson(Reckitt) Description and Business Overview
6.2.3 Mead Johnson(Reckitt) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mead Johnson(Reckitt) HMO Infant Formula Product Portfolio
6.2.5 Mead Johnson(Reckitt) Recent Developments/Updates
6.3 Nestlé(Wyeth Nutrition)
6.3.1 Nestlé(Wyeth Nutrition) Company Information
6.3.2 Nestlé(Wyeth Nutrition) Description and Business Overview
6.3.3 Nestlé(Wyeth Nutrition) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nestlé(Wyeth Nutrition) HMO Infant Formula Product Portfolio
6.3.5 Nestlé(Wyeth Nutrition) Recent Developments/Updates
6.4 Danone (Aptamil)
6.4.1 Danone (Aptamil) Company Information
6.4.2 Danone (Aptamil) Description and Business Overview
6.4.3 Danone (Aptamil) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Danone (Aptamil) HMO Infant Formula Product Portfolio
6.4.5 Danone (Aptamil) Recent Developments/Updates
6.5 FrieslandCampina (Friso)
6.5.1 FrieslandCampina (Friso) Company Information
6.5.2 FrieslandCampina (Friso) Description and Business Overview
6.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
6.5.5 FrieslandCampina (Friso) Recent Developments/Updates
6.6 Biostime
6.6.1 Biostime Company Information
6.6.2 Biostime Description and Business Overview
6.6.3 Biostime HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biostime HMO Infant Formula Product Portfolio
6.6.5 Biostime Recent Developments/Updates
6.7 Yili Group (Ausnutria Dairy)
6.7.1 Yili Group (Ausnutria Dairy) Company Information
6.7.2 Yili Group (Ausnutria Dairy) Description and Business Overview
6.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
6.7.5 Yili Group (Ausnutria Dairy) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMO Infant Formula Industry Chain Analysis
7.2 HMO Infant Formula Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMO Infant Formula Production Mode & Process Analysis
7.4 HMO Infant Formula Sales and Marketing
7.4.1 HMO Infant Formula Sales Channels
7.4.2 HMO Infant Formula Distributors
7.5 HMO Infant Formula Customer Analysis
8 HMO Infant Formula Market Dynamics
8.1 HMO Infant Formula Industry Trends
8.2 HMO Infant Formula Market Drivers
8.3 HMO Infant Formula Market Challenges
8.4 HMO Infant Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global HMO Infant Formula Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global HMO Infant Formula Market Value by Sales Channel (2024 VS 2031) & (US$ Million)
 Table 3. Global HMO Infant Formula Market Competitive Situation by Manufacturers in 2024
 Table 4. Global HMO Infant Formula Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global HMO Infant Formula Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global HMO Infant Formula Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global HMO Infant Formula Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market HMO Infant Formula Average Price (US$/kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of HMO Infant Formula, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HMO Infant Formula, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HMO Infant Formula, Product Type & Application
 Table 12. Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HMO Infant Formula by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HMO Infant Formula as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HMO Infant Formula Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global HMO Infant Formula Sales by Region (2020-2025) & (Tons)
 Table 18. Global HMO Infant Formula Sales Market Share by Region (2020-2025)
 Table 19. Global HMO Infant Formula Sales by Region (2026-2031) & (Tons)
 Table 20. Global HMO Infant Formula Sales Market Share by Region (2026-2031)
 Table 21. Global HMO Infant Formula Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global HMO Infant Formula Revenue Market Share by Region (2020-2025)
 Table 23. Global HMO Infant Formula Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global HMO Infant Formula Revenue Market Share by Region (2026-2031)
 Table 25. North America HMO Infant Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America HMO Infant Formula Sales by Country (2020-2025) & (Tons)
 Table 27. North America HMO Infant Formula Sales by Country (2026-2031) & (Tons)
 Table 28. North America HMO Infant Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America HMO Infant Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe HMO Infant Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe HMO Infant Formula Sales by Country (2020-2025) & (Tons)
 Table 32. Europe HMO Infant Formula Sales by Country (2026-2031) & (Tons)
 Table 33. Europe HMO Infant Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe HMO Infant Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific HMO Infant Formula Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific HMO Infant Formula Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific HMO Infant Formula Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific HMO Infant Formula Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific HMO Infant Formula Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America HMO Infant Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America HMO Infant Formula Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America HMO Infant Formula Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America HMO Infant Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America HMO Infant Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa HMO Infant Formula Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa HMO Infant Formula Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa HMO Infant Formula Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa HMO Infant Formula Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa HMO Infant Formula Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global HMO Infant Formula Sales (Tons) by Type (2020-2025)
 Table 51. Global HMO Infant Formula Sales (Tons) by Type (2026-2031)
 Table 52. Global HMO Infant Formula Sales Market Share by Type (2020-2025)
 Table 53. Global HMO Infant Formula Sales Market Share by Type (2026-2031)
 Table 54. Global HMO Infant Formula Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global HMO Infant Formula Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global HMO Infant Formula Revenue Market Share by Type (2020-2025)
 Table 57. Global HMO Infant Formula Revenue Market Share by Type (2026-2031)
 Table 58. Global HMO Infant Formula Price (US$/kg) by Type (2020-2025)
 Table 59. Global HMO Infant Formula Price (US$/kg) by Type (2026-2031)
 Table 60. Global HMO Infant Formula Sales (Tons) by Sales Channel (2020-2025)
 Table 61. Global HMO Infant Formula Sales (Tons) by Sales Channel (2026-2031)
 Table 62. Global HMO Infant Formula Sales Market Share by Sales Channel (2020-2025)
 Table 63. Global HMO Infant Formula Sales Market Share by Sales Channel (2026-2031)
 Table 64. Global HMO Infant Formula Revenue (US$ Million) by Sales Channel (2020-2025)
 Table 65. Global HMO Infant Formula Revenue (US$ Million) by Sales Channel (2026-2031)
 Table 66. Global HMO Infant Formula Revenue Market Share by Sales Channel (2020-2025)
 Table 67. Global HMO Infant Formula Revenue Market Share by Sales Channel (2026-2031)
 Table 68. Global HMO Infant Formula Price (US$/kg) by Sales Channel (2020-2025)
 Table 69. Global HMO Infant Formula Price (US$/kg) by Sales Channel (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Abbott HMO Infant Formula Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Mead Johnson(Reckitt) Company Information
 Table 76. Mead Johnson(Reckitt) Description and Business Overview
 Table 77. Mead Johnson(Reckitt) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Mead Johnson(Reckitt) HMO Infant Formula Product
 Table 79. Mead Johnson(Reckitt) Recent Developments/Updates
 Table 80. Nestlé(Wyeth Nutrition) Company Information
 Table 81. Nestlé(Wyeth Nutrition) Description and Business Overview
 Table 82. Nestlé(Wyeth Nutrition) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Nestlé(Wyeth Nutrition) HMO Infant Formula Product
 Table 84. Nestlé(Wyeth Nutrition) Recent Developments/Updates
 Table 85. Danone (Aptamil) Company Information
 Table 86. Danone (Aptamil) Description and Business Overview
 Table 87. Danone (Aptamil) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Danone (Aptamil) HMO Infant Formula Product
 Table 89. Danone (Aptamil) Recent Developments/Updates
 Table 90. FrieslandCampina (Friso) Company Information
 Table 91. FrieslandCampina (Friso) Description and Business Overview
 Table 92. FrieslandCampina (Friso) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. FrieslandCampina (Friso) HMO Infant Formula Product
 Table 94. FrieslandCampina (Friso) Recent Developments/Updates
 Table 95. Biostime Company Information
 Table 96. Biostime Description and Business Overview
 Table 97. Biostime HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Biostime HMO Infant Formula Product
 Table 99. Biostime Recent Developments/Updates
 Table 100. Yili Group (Ausnutria Dairy) Company Information
 Table 101. Yili Group (Ausnutria Dairy) Description and Business Overview
 Table 102. Yili Group (Ausnutria Dairy) HMO Infant Formula Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Yili Group (Ausnutria Dairy) HMO Infant Formula Product
 Table 104. Yili Group (Ausnutria Dairy) Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. HMO Infant Formula Distributors List
 Table 108. HMO Infant Formula Customers List
 Table 109. HMO Infant Formula Market Trends
 Table 110. HMO Infant Formula Market Drivers
 Table 111. HMO Infant Formula Market Challenges
 Table 112. HMO Infant Formula Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HMO Infant Formula
 Figure 2. Global HMO Infant Formula Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global HMO Infant Formula Market Share by Type: 2024 & 2031
 Figure 4. 2'-Fucosyllactose (2'-FL) Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global HMO Infant Formula Market Value by Sales Channel (2020-2031) & (US$ Million)
 Figure 7. Global HMO Infant Formula Market Share by Sales Channel: 2024 & 2031
 Figure 8. Online Channel
 Figure 9. Specialty Store
 Figure 10. Supermarket
 Figure 11. Others
 Figure 12. Global HMO Infant Formula Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global HMO Infant Formula Market Size (2020-2031) & (US$ Million)
 Figure 14. Global HMO Infant Formula Sales (2020-2031) & (Tons)
 Figure 15. Global HMO Infant Formula Average Price (US$/kg) & (2020-2031)
 Figure 16. HMO Infant Formula Report Years Considered
 Figure 17. HMO Infant Formula Sales Share by Manufacturers in 2024
 Figure 18. Global HMO Infant Formula Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest HMO Infant Formula Players: Market Share by Revenue in HMO Infant Formula in 2024
 Figure 20. HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global HMO Infant Formula Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America HMO Infant Formula Sales Market Share by Country (2020-2031)
 Figure 23. North America HMO Infant Formula Revenue Market Share by Country (2020-2031)
 Figure 24. United States HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe HMO Infant Formula Sales Market Share by Country (2020-2031)
 Figure 27. Europe HMO Infant Formula Revenue Market Share by Country (2020-2031)
 Figure 28. Germany HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific HMO Infant Formula Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific HMO Infant Formula Revenue Market Share by Region (2020-2031)
 Figure 35. China HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America HMO Infant Formula Sales Market Share by Country (2020-2031)
 Figure 43. Latin America HMO Infant Formula Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Colombia HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa HMO Infant Formula Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa HMO Infant Formula Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE HMO Infant Formula Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of HMO Infant Formula by Type (2020-2031)
 Figure 54. Global Revenue Market Share of HMO Infant Formula by Type (2020-2031)
 Figure 55. Global HMO Infant Formula Price (US$/kg) by Type (2020-2031)
 Figure 56. Global Sales Market Share of HMO Infant Formula by Sales Channel (2020-2031)
 Figure 57. Global Revenue Market Share of HMO Infant Formula by Sales Channel (2020-2031)
 Figure 58. Global HMO Infant Formula Price (US$/kg) by Sales Channel (2020-2031)
 Figure 59. HMO Infant Formula Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools